Naureen Starling

Naureen Starling is a consultant medical oncologist at The Royal Marsden specialising in gastrointestinal cancers, director of the Royal Marsden Clinical Trials Unit and a reader in the Division of Clinical Studies at the Institute of Cancer Research; she is training programme director for medical oncology and chairs the pan-London specialist training committee. She is a senior author on the TRACC Part B analysis, which showed that a tissue-free assay combining genomic and methylation signals can detect minimal residual disease after surgery for early colorectal cancer across a UK multicentre cohort.